Navigation Links
Regenerative Medicine | Ottawa Senators Player Milan Michalek Credited Therapy For Recovery From Knee Injury
Date:1/12/2014

(PRWEB) January 12, 2014

Veteran NHL player Milan Michalek faced a decision after last season ended: surgery to repair his injured knee, or an innovative, non-invasive treatment known as platelet-rich plasma therapy. According to the Ottawa Sun on September 9,2013, Michalek declare himself fit after receiving the innovative therapy. Following the examples set by superstar athletes like Tiger Woods, Kobe Bryant and A-Rod, Michalek chose the latter, traveling to Germany to receive treatment for a week. By September, Michalek told journalists he was "100% and ready to go," and he has played thus far this season without reporting pain or re-injury.

"Such results are not uncommon," says James Hays, CEO of PlasmaGenix, Inc. "And as more and more professional athletes find relief through various forms of regenerative medicine and sing its praises, we're seeing increased interest from athletes of every skill level, as well as from patients with other orthopedic complaints."

Regenerative medicine has the potential to supercharge healing. Through a series of injections of small, concentrated amounts of a patient's own blood into damaged tissue, growth factors can speed healing and often quickly reduces or eliminates pain.

Dr. John Simmonds, an orthopedic surgeon and the Chief Medical Officer of PlasmaGenix, Inc. explains why regenerative medicine has become the treatment of choice for a wide variety of injuries and conditions: "First, before opting for surgery, it's important to explore non-invasive treatments like PRP. Second, although treating injuries and chronic conditions with medications may decrease inflammation and/or pain, such drugs are accompanied by side effects, and are often quite expensive."

PlasmaGenix has developed proprietary processes and treatments that use the power of regenerative medicine to treat joint and tendon pain, ankle sprains, heel pain, and plantar fasciitis. The Institute also uses PRP injections to improve poor circulation, treat diabetic neuropathy and HIV neuropathy.

About PlasmaGenix
PlasmaGenix is a biologics company located in Inglewood, California. Our three lead products, PlasmaNeu, PlasmaGen and PlasmaPro, have been used for over a decade to treat chronic non-healing wounds and preventing amputations in high risk populations, and? peripheral neuropathy associated with HIV and Diabetes.Science has recently shown that the body has enormous potential to heal itself. Regenerative medicine is an exciting area in medicine that is evolving very rapidly and PlasmaGenix is proud to be at the forefront of developing new therapeutics to treat a wide variety of chronic conditions. We can now deliver products to accelerate the body’s own natural healing mechanisms and enrich the body’s inherent ability to repair and regenerate.

The culmination of over 3 decades of clinical experience and research gave birth to PlasmaGenix which is poised to be a leader in the field of regenerative medicine. To date, PlasmaGenix has successfully treated over 10,000 patients for various neurologic conditions, chronic non-healing wounds, sports related injures as well as muscular sclerosis and Charcot-Marie Tooth disease.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11481480.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Growing Interest in Regenerative Medicine to Drive the Mesenchymal Stem Cells Market, According to a Soon to Be Released Report by Global Industry Analysts, Inc.
2. Startup to Strengthen Synthetic Biology and Regenerative Medicine Industries with Cutting Edge Cell Products
3. Dr. Ross Rich of Cave Creek Equine Recently Presented the Outcome of 42 Horses with Stifle Injuries Treated with Vet-Stem Regenerative Cell Therapy
4. Vet-Stem, Inc. Proudly Announces Distribution Agreement with Animal Health International, Inc. for Regenerative Cell Therapies
5. Dr. Ross Rich of Cave Creek Equine to Present at North American Veterinary Regenerative Medicine Association Conference
6. Vet-Stem, Inc. Founder and CEO, Dr. Robert Harman, to Speak at North American Veterinary Regenerative Medicine Association Conference
7. ViaCyte Granted Over 20 Patents in 2013 Further Establishing the Company as a Leader in the Field of Regenerative Medicine
8. Global Stem Cells Group, Inc. Announces Worldwide Alliance with EmCyte Corp. to Promote In-office Regenerative Medicine Solutions
9. Pets Best Insurance Announces Stem Cell Therapy and Regenerative Veterinary Medicine by Vet-Stem, Inc. Covered by Their Pet Health Insurance
10. Vet-Stem, Inc. Founder and CEO, Robert Harman, DVM, Invited to Speak at the Adult Stem Cell Therapy and Regenerative Medicine Conference
11. The Veterinary Cooperative (TVC) and Vet-Stem, Inc. Announce an Exclusive Partnership to Offer Regenerative Medicine and Stem Cell Therapy to Over 300 Member Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published ... how a patient who developed lymphedema after being treated for breast cancer benefitted from ... the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a company ... to the medical community, has closed its Series A ... Nunez . "We have received a commitment ... capital we need to meet our current goals," stated ... us the runway to complete validation on the current ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology:
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
Breaking Biology News(10 mins):